Youwei Lin

877 total citations
30 papers, 610 citations indexed

About

Youwei Lin is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Youwei Lin has authored 30 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 12 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Youwei Lin's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (7 papers) and T-cell and B-cell Immunology (6 papers). Youwei Lin is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (7 papers) and T-cell and B-cell Immunology (6 papers). Youwei Lin collaborates with scholars based in Japan, United States and China. Youwei Lin's co-authors include Takashi Yamamura, Wakiro Sato, Sachiko Miyake, Tomoko Okamoto, Miho Murata, Shinji Oki, Masafumi Ogawa, M. Araki, Stephan von Hörsten and Toshimasa Aranami and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Brain.

In The Last Decade

Youwei Lin

26 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youwei Lin Japan 11 188 181 167 89 83 30 610
Johanna Breuer Germany 12 233 1.2× 143 0.8× 189 1.1× 43 0.5× 120 1.4× 22 576
Hyunjung Baek South Korea 17 125 0.7× 190 1.0× 20 0.1× 91 1.0× 85 1.0× 33 744
Mahasweta Dutt United States 8 78 0.4× 200 1.1× 225 1.3× 7 0.1× 22 0.3× 10 653
Faisal Adhami United States 6 61 0.3× 282 1.6× 29 0.2× 84 0.9× 15 0.2× 8 678
Stine Rasmussen Denmark 10 193 1.0× 147 0.8× 152 0.9× 6 0.1× 63 0.8× 10 729
Tarik Touil Morocco 11 431 2.3× 135 0.7× 211 1.3× 3 0.0× 133 1.6× 17 746
Carme Costa Spain 16 143 0.8× 332 1.8× 69 0.4× 6 0.1× 44 0.5× 34 604
Isabel Mayo Spain 12 34 0.2× 213 1.2× 20 0.1× 30 0.3× 32 0.4× 14 482
Francesca Cignarella United States 7 244 1.3× 318 1.8× 162 1.0× 3 0.0× 35 0.4× 9 853
Min‐Ji Kang South Korea 17 105 0.6× 523 2.9× 11 0.1× 25 0.3× 33 0.4× 38 1.1k

Countries citing papers authored by Youwei Lin

Since Specialization
Citations

This map shows the geographic impact of Youwei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youwei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youwei Lin more than expected).

Fields of papers citing papers by Youwei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youwei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youwei Lin. The network helps show where Youwei Lin may publish in the future.

Co-authorship network of co-authors of Youwei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Youwei Lin. A scholar is included among the top collaborators of Youwei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youwei Lin. Youwei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Youwei, Yuanshan Han, & Yuhong Wang. (2024). Traditional Chinese medicine for cardiovascular disease: efficacy and safety. Frontiers in Cardiovascular Medicine. 11. 1419169–1419169. 3 indexed citations
3.
Sato, Wakiro, Kimitoshi Kimura, Youwei Lin, et al.. (2024). High frequency of circulating non-classical monocytes is associated with stable remission in relapsing-remitting multiple sclerosis. Immunological Medicine. 47(3). 151–165. 1 indexed citations
4.
Sato, Wakiro, Yukio Kimura, Youwei Lin, et al.. (2024). CD11c high B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis Optica. Neurology Neuroimmunology & Neuroinflammation. 11(2). e200206–e200206. 7 indexed citations
5.
Katsumoto, Atsuko, Tomoko Okamoto, Wakiro Sato, et al.. (2024). Ofatumumab for multiple sclerosis with disability accumulation. Journal of the Neurological Sciences. 468. 123356–123356.
6.
Sato, Wakiro, Daisuke Noto, M. Araki, et al.. (2023). First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 16. 4223443241–4223443241. 10 indexed citations
8.
Matsuoka, Takako, M. Araki, Youwei Lin, et al.. (2023). Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder. Neurology Neuroimmunology & Neuroinflammation. 11(1). 6 indexed citations
9.
Lin, Youwei, Shun Sakuraba, Chandirasegaran Massilamany, et al.. (2023). Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues. Journal of Autoimmunity. 140. 103094–103094. 2 indexed citations
10.
Okamoto, Tomoko, Youwei Lin, Atsuko Katsumoto, et al.. (2023). Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis. Frontiers in Immunology. 14. 1133444–1133444. 1 indexed citations
11.
Okamoto, Tomoko, et al.. (2023). Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis. Journal of Clinical Medicine. 12(21). 6948–6948. 2 indexed citations
12.
Lin, Youwei, et al.. (2022). Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study. Therapeutic Apheresis and Dialysis. 27(1). 123–135. 8 indexed citations
13.
Kadowaki, Atsushi, et al.. (2019). Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis. Brain. 142(4). 916–931. 57 indexed citations
14.
Kimura, Kimitoshi, Masakazu Nakamura, Wakiro Sato, et al.. (2016). Disrupted balance of T cells under natalizumab treatment in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 3(2). e210–e210. 27 indexed citations
15.
Nakamura, Masakazu, Takako Matsuoka, Norio Chihara, et al.. (2014). Differential effects of fingolimod on B-cell populations in multiple sclerosis. Multiple Sclerosis Journal. 20(10). 1371–1380. 55 indexed citations
16.
Sanvito, Lara, Norio Chihara, Tomoko Okamoto, et al.. (2011). Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroids. Journal of Neuroimmunology. 236(1-2). 111–117. 9 indexed citations
17.
Chihara, Norio, Toshiyuki Yamamoto, Youwei Lin, et al.. (2009). Severe kyphosis and esophagus hiatal hernia affected on the levodopa absorption of a patient with Parkinson's disease. Rinsho Shinkeigaku. 49(8). 493–496. 2 indexed citations
18.
Miyake, Sachiko, Miho Mizuno, Chiharu Tomi, et al.. (2009). Suppression of Experimental Autoimmune Encephalomyelitis by Ghrelin. The Journal of Immunology. 183(4). 2859–2866. 76 indexed citations
19.
Wang, Yanhua, Cong‐Fen Gao, Yu Cheng Zhu, et al.. (2008). Buprofezin susceptibility survey, resistance selection and preliminary determination of the resistance mechanism in Nilaparvata lugens (Homoptera: Delphacidae). Pest Management Science. 64(10). 1050–1056. 95 indexed citations
20.
Bedoui, Sammy, Sachiko Miyake, Youwei Lin, et al.. (2003). Neuropeptide Y (NPY) Suppresses Experimental Autoimmune Encephalomyelitis: NPY1 Receptor-Specific Inhibition of Autoreactive Th1 Responses In Vivo. The Journal of Immunology. 171(7). 3451–3458. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026